Teva wraps up $4.95B Ratiopharm buyout; Novartis wins Alcon deal OK from EU, Canada;

@FiercePharma: Sanofi deal could bring $22M bonus for Termeer. Article | Follow @FiercePharma

> Teva Pharmaceutical has solidified operations further in Europe, announcing that it completed a $4.95 billion buyout of German drugmaker Ratiopharm. Teva's release | Article

> Swiss drugmaker Novartis has received approval from EU and Canadian regulators to buy a minority stake in Alcon, making it easier for it to take full control of the U.S. eyecare group. Report

> Dr. Reddy's has launched Cresp, its new biosimilar version of the Amgen anemia drug Aranesp, in India. Dr. Reddy's release | Story

> King Pharmaceuticals' quarterly profit was cut in half as sales of its muscle-relaxant Skelaxin plunged 95 percent due to generic competition, but overall results slightly topped expectations. Item

> In a twist to the tale of drug patent infringement cases in the U.S., Indian drug company Lupin has sued Ranbaxy Laboratories in a U.S. court. News

Biotech News

  @FierceBiotech: Mayo Clinic to launch center for social media. Report | Follow @FierceBiotech

  @JohnCFierce: It's rare to see a Ph3 drug with the kind of compelling, clean profile that telaprevir has.  | Follow @JohnCFierce

> Elan, Transition push ahead with troubled Alzheimer's drug. Item

> TetraLogic nabs $32 million round for lead cancer therapy. Article

> Endo buying partner in pain Penwest for $168 million. News

> Report: China readies $1.5 billion plan to bolster biotech. Report

> Vertex's telaprevir cuts hep C treatment time in half. Story

Biotech Research News

> Gene recipe regenerates damaged heart tissue. Story

> Scientists look to newt to regenerate tissue in mice. Article

> Debate over chimps pits lawmakers against researchers. News

> Investigators create cancer-fighting T cell receptors. Item

> Lab accident opens door to new fertility treatment. Article

> Leptin fades as a prime obesity target. News

Manufacturing News

> Indian packager Bilcare looks west for expansion. Report

> Gilead SEC filing anticipates FDA warning letter. Item

> FDA to skip legal review of warning letters. News

> Distribution change affects supply chain balance of power. Article

> Private labeler Activis revs up for Tylenol shortfall. Item

> Sun enjoys fleeting profit boost from oxaliplatin. Story

And Finally... A new study suggests that a 50-year-old drug commonly used as an anesthetic for humans and animals--and abused, as the drug called Special K--may deliver almost instant relief in some of the most troublesome cases of bipolar depression. Story